Safety and efficacy of nivolumab monotherapy in recurrent or metastatic cervical, vaginal, or vulvar carcinoma: Results from the phase I/II CheckMate 358 Trial - Naumann, RW; Hollebecque, A; Meyer, T (J Clin Oncol, 2019)
et al.